MedXCRO
↗Toledo, USA
MedXCRO is a specialized Contract Research Organization (CRO) fully dedicated to the neuroscience sector. The company serves as a global development hub for therapeutic innovators, particularly in the areas of neurovascular and peripheral products. They offer end-to-end solutions including study planning, regulatory affairs, site management, and data management.
Headquartered in Toledo, Ohio, MedXCRO is known for its rapid trial startup and enrollment capabilities. It frequently partners with leading neurointerventionalists and medical device companies to execute high-stakes clinical trials for intracranial aneurysm treatments and stroke intervention technologies.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1-50
Revenue:$1M-$5M
Founded:2020
Ownership:private
Status:operating
FUNDING
Stage:Self-funded
PIPELINE
Stage:Commercial
Lead Drug Stage:Phase 2/3 (Device IDE)
Modalities:Medical Devices, Endovascular Implants, Neuro-interventional tools
Active Trials:5
Trial Phases:Phase 1: 1 | Phase 2: 2 | Phase 3: 2
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Galaxy Therapeutics (SEAL Trial), Stryker (TARGET Registry), St. Vincent Mercy Medical Center
COMPETITION
Position:Niche Player
Competitors:Medpace, IQVIA, ICON plc, Neurovascular Research Group
LEADERSHIP
Key Executives:
Osama O. Zaidat, MD - Scientific Founder / Lead Investigator
M. Kaffashi - Clinical Operations Leader
Scientific Founders:Osama O. Zaidat
LINKS
Website:medxcro.co
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with MedXCRO. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.